Last updated: 8 December 2021 at 5:10pm EST

Corporate Investors Viii, L... Net Worth




The estimated Net Worth of Corporate Investors Viii, L... is at least $7.09 milliard dollars as of 21 September 2020. Corporate L owns over 24,702,175 units of PPD Inc stock worth over $7,429,485 and over the last 4 years Corporate sold PPD stock worth over $7,082,644,169.

Corporate L PPD stock SEC Form 4 insiders trading

Corporate has made over 2 trades of the PPD Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Corporate sold 132,841,266 units of PPD stock worth $6,309,960,135 on 8 December 2021.

The largest trade Corporate's ever made was selling 132,841,266 units of PPD Inc stock on 8 December 2021 worth over $6,309,960,135. On average, Corporate trades about 78,771,721 units every 222 days since 2020. As of 21 September 2020 Corporate still owns at least 157,138 units of PPD Inc stock.

You can see the complete history of Corporate L stock trades at the bottom of the page.



Insiders trading at PPD Inc

Over the last 22 years, insiders at PPD Inc have traded over $14,532,346,241 worth of PPD Inc stock and bought 130,455 units worth $3,520,800 . The most active insiders traders include Corporate Investors Viii, L..., Corporate Investors Vii, Lt... et Group Management L.L.C.Carl.... On average, PPD Inc executives and independent directors trade stock every 53 days with the average trade being worth of $124,899,671. The most recent stock trade was executed by Corporate Investors Viii, L... on 8 December 2021, trading 132,841,266 units of PPD stock currently worth $6,309,960,135.



What does PPD Inc do?

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Company's customers include pharmaceutical, biotechnology, medical device, academic and government organization s. With offices in 46 countries and more than 26,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.



Complete history of Corporate L stock trades at PPD Inc

Initié
Trans.
Transaction
Prix ​​total
Corporate Investors Viii, L...
Vente $6,309,960,135
8 Dec 2021
Corporate Investors Viii, L...
Vente $772,684,034
21 Sep 2020


PPD Inc executives and stock owners

PPD Inc executives and other stock owners filed with the SEC include: